Bank of New York Mellon’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61.8M Buy
635,366
+93,297
+17% +$9.42M 0.01% 871
2025
Q4
$43.2M Buy
542,069
+12,799
+2% +$839K 0.01% 1092
2025
Q3
$24.7M Buy
529,270
+34,657
+7% +$1.36M ﹤0.01% 1427
2025
Q2
$18.2M Sell
494,613
-88,108
-15% -$3.38M ﹤0.01% 1569
2025
Q1
$20.6M Buy
582,721
+13,706
+2% +$556K ﹤0.01% 1486
2024
Q4
$24.9M Buy
569,015
+36,705
+7% +$1.85M ﹤0.01% 1442
2024
Q3
$24.1M Sell
532,310
-112,943
-18% -$4.92M ﹤0.01% 1466
2024
Q2
$25M Buy
645,253
+115,844
+22% +$4.33M ﹤0.01% 1444
2024
Q1
$17.1M Sell
529,409
-51,807
-9% -$1.54M ﹤0.01% 1664
2023
Q4
$16.7M Buy
581,216
+160,850
+38% +$3.87M ﹤0.01% 1694
2023
Q3
$11.6M Buy
420,366
+8,825
+2% +$262K ﹤0.01% 1858
2023
Q2
$11M Buy
411,541
+118,930
+41% +$2.92M ﹤0.01% 1906
2023
Q1
$6.34M Buy
292,611
+33,343
+13% +$821K ﹤0.01% 2168
2022
Q4
$6.18M Buy
259,268
+1,403
+0.5% +$29.8K ﹤0.01% 2209
2022
Q3
$5.08M Buy
257,865
+59,854
+30% +$1.32M ﹤0.01% 2278
2022
Q2
$3.86M Sell
198,011
-63,797
-24% -$1.24M ﹤0.01% 2462
2022
Q1
$6.68M Sell
261,808
-6,749
-3% -$147K ﹤0.01% 2273
2021
Q4
$6.76M Buy
268,557
+342
+0.1% +$9.64K ﹤0.01% 2308
2021
Q3
$7.38M Buy
268,215
+35,981
+15% +$1.05M ﹤0.01% 2291
2021
Q2
$7.37M Buy
232,234
+90,332
+64% +$3.15M ﹤0.01% 2291
2021
Q1
$6.51M Buy
141,902
+4,493
+3% +$201K ﹤0.01% 2323
2020
Q4
$5.44M Buy
137,409
+8,049
+6% +$318K ﹤0.01% 2317
2020
Q3
$4.5M Buy
129,360
+73,404
+131% +$2.03M ﹤0.01% 2270
2020
Q2
$1.77M Buy
55,956
+16,888
+43% +$531K ﹤0.01% 2757
2020
Q1
$856K Buy
+39,068
New +$1.08M ﹤0.01% 3087

Other funds holding RVMD